Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Till Milde

Showing results (41-50 of 161) with videos related to

Pageof 17
Sort By:
Clinical Pharmacology and Therapeutics|May 29, 2021
A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol DevelopmentLydia Beck, Ruth Witt, Martina Nesper-Brock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Molecular staging of intracranial ependymoma in children and adultsAndrey Korshunov, Hendrik Witt, Thomas Hielscher, et al.
Cell Cycle (Georgetown, Tex.)|April 11, 2018
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitorsMichael Daskalakis, David Brocks, Yi-Hua Sheng, et al.
Molecular Oncology|January 30, 2018
Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastomaMargaret Stromecki, Nazanin Tatari, Ludivine Coudière Morrison, et al.
Journal of Neuro-Oncology|October 12, 2012
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatmentTill Milde, Marco Lodrini, Larissa Savelyeva, et al.
Clinical Pharmacology and Therapeutics|July 13, 2023
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical StudiesNora Jamaladdin, Romain Sigaud, Daniela Kocher, et al.
The Journal of Clinical Investigation|December 5, 2006
Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularizationHans-Georg Kopp, Andrea T Hooper, M Johan Broekman, et al.
The Journal of Clinical Investigation|March 16, 2011
An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in miceJan Gronych, Andrey Korshunov, Josephine Bageritz, et al.
Brain Pathology (Zurich, Switzerland)|May 10, 2012
Nestin expression identifies ependymoma patients with poor outcomeTill Milde, Thomas Hielscher, Hendrik Witt, et al.
Neuro-Oncology|October 8, 2024
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort studyEdward C Schwalbe, Janet C Lindsey, Marina Danilenko, et al.
Pageof 17

Showing results (41-50 of 161) with videos related to

Sort By:
Pageof 17
Clinical Pharmacology and Therapeutics|May 29, 2021
A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol DevelopmentLydia Beck, Ruth Witt, Martina Nesper-Brock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Molecular staging of intracranial ependymoma in children and adultsAndrey Korshunov, Hendrik Witt, Thomas Hielscher, et al.
Cell Cycle (Georgetown, Tex.)|April 11, 2018
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitorsMichael Daskalakis, David Brocks, Yi-Hua Sheng, et al.
Molecular Oncology|January 30, 2018
Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastomaMargaret Stromecki, Nazanin Tatari, Ludivine Coudière Morrison, et al.
Journal of Neuro-Oncology|October 12, 2012
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatmentTill Milde, Marco Lodrini, Larissa Savelyeva, et al.
Clinical Pharmacology and Therapeutics|July 13, 2023
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical StudiesNora Jamaladdin, Romain Sigaud, Daniela Kocher, et al.
The Journal of Clinical Investigation|December 5, 2006
Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularizationHans-Georg Kopp, Andrea T Hooper, M Johan Broekman, et al.
The Journal of Clinical Investigation|March 16, 2011
An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in miceJan Gronych, Andrey Korshunov, Josephine Bageritz, et al.
Brain Pathology (Zurich, Switzerland)|May 10, 2012
Nestin expression identifies ependymoma patients with poor outcomeTill Milde, Thomas Hielscher, Hendrik Witt, et al.
Neuro-Oncology|October 8, 2024
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort studyEdward C Schwalbe, Janet C Lindsey, Marina Danilenko, et al.
Pageof 17